Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246
Trial details
- Registry ID
- NCT00907803
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Tecovirimat
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246NCT00907803 | SIGA Technologies | Phase 2 | Completed | 2010-01Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |